6533b7ddfe1ef96bd12750db
RESEARCH PRODUCT
Primary Analysis of Phase 2 Results for Cemiplimab in Patients (pts) with Locally Advanced Basal Cell Carcinoma (laBCC) who Progress on or are Intolerant to Hedgehog Inhibitors (HHIs)
Caroline RobertEbony CoatesMatthew G. FuryJens UlrichVincent De GiorgiAlmudena Fernandez OrlandMichael R. MigdenAnne Lynn S. ChangLisa LicitraMartin KaatzNathalie FlaschiClaas UlrichTimothy BowlerEmmanuel OkoyeOliver BechterFrank SeebachGavin ThurstonRalf GutzmerZeynep ErogluKarl D. LewisCarmen LoquaiIsrael LowyStephanie DalleVladimir JankovicIoannis D. BassukasNicole Basset-segiunAlexander J. StratigosAleksandar SekulicKetty PerisAxel HauschildSiyu LiKosalai Kal MohanSusana PuigReinhard Dummersubject
business.industryLocally advancedmedicineCancer researchBasal cell carcinomaIn patientmedicine.diseasebusinessHedgehogdescription
Abstract not available.
year | journal | country | edition | language |
---|---|---|---|---|
2021-01-01 | SKIN The Journal of Cutaneous Medicine |